Literature DB >> 15784220

[Is procalcitonin able to help in pediatric appendicitis diagnosis?].

D B Kouame1, M A Garrigue, H Lardy, M C Machet, B Giraudeau, M Robert.   

Abstract

BACKGROUND: Appendicitis clinical diagnosis in children is difficult and the acute inflammatory markers hyperleucocytis and CRP do not contribute to it.
OBJECTIVE: To study the predictive value of procalcitonin (PCT) and to assess variations of its serum level according to inflammatory lesions in paediatric appendicitis. PATIENTS AND
METHOD: Among 101 children aged two and 15, hospitalized for painful abdominal syndromes, 70 underwent operation for acute appendicitis and appendiceal peritonitis, 31 had no operation. PCT was evaluated in all children, normal serum concentration was <0,5 microg/L. Every appendicectomy part has been examined through histological analysis to confirm the diagnosis and the histological lesions have been classified into three categories according to their severity.
RESULTS: Out of 70 appendix analysed at histology, 68 (97%) were healthy and 2 (3%)were unhealthy. Among the 68 cases of healthy appendix, 19 had a PCT higher than 0,5 microg/L and among 33 cases of unhealthy appendix 4 had a PCT higher than 0,5 microg/L. The PCT mean of healthy children was not significantly different from unhealthy appendix population, appendicitis prevalence was 0,67, PCT sensitivity 28%: IC 95% [18-40], specificity 88%: IC 95% [72-97], positive predictive value 83%: IC 95% [61-95], and negative predictive value 37%: IC 95% [26-49]. PCT mean increases with the severity of inflammatory lesions of the appendix (P=0,0051).
CONCLUSION: PCT has not a good predictive value in acute paediatric appendicitis but remains a good indicator of severity in paediatric appendicitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784220     DOI: 10.1016/j.anchir.2004.12.004

Source DB:  PubMed          Journal:  Ann Chir        ISSN: 0003-3944


  7 in total

1.  Procalcitonin as the biomarker of inflammation in diagnosis of appendicitis in pediatric patients and prevention of unnecessary appendectomies.

Authors:  Vishal Chandel; Sajjid Hussain Batt; Mohammad Younis Bhat; Nadeem Ulnazeer Kawoosa; Adfar Yousuf; Babar Rashid Zargar
Journal:  Indian J Surg       Date:  2010-12-01       Impact factor: 0.656

2.  A prospective bicenter study investigating the diagnostic value of procalcitonin in patients with acute appendicitis.

Authors:  Michael Sand; X V Trullen; F G Bechara; X F Pala; D Sand; G Landgrafe; B Mann
Journal:  Eur Surg Res       Date:  2009-08-07       Impact factor: 1.745

3.  The diagnostic value of D-dimer, procalcitonin and CRP in acute appendicitis.

Authors:  Bulent Kaya; Baris Sana; Cengiz Eris; Koray Karabulut; Orhan Bat; Riza Kutanis
Journal:  Int J Med Sci       Date:  2012-11-13       Impact factor: 3.738

4.  Evaluation of procalcitonin as a biomarker of diagnosis, severity and postoperative complications in adult patients with acute appendicitis.

Authors:  Mohammad Vaziri; Fahimeh Ehsanipour; Abdolreza Pazouki; Zeinab Tamannaie; Roohollah Taghavi; Mohaddese Pishgahroudsari; Fatemeh Jesmi; Shahla Chaichian
Journal:  Med J Islam Repub Iran       Date:  2014-07-07

5.  The Use of Metabolomics and Inflammatory Mediator Profiling Provides a Novel Approach to Identifying Pediatric Appendicitis in the Emergency Department.

Authors:  Nusrat S Shommu; Craig N Jenne; Jaime Blackwood; Dori-Ann Martin; Ari R Joffe; Robin Eccles; Mary Brindle; Ijab Khanafer; Hans J Vogel; Graham C Thompson
Journal:  Sci Rep       Date:  2018-03-06       Impact factor: 4.379

Review 6.  Biomarkers of acute appendicitis: systematic review and cost-benefit trade-off analysis.

Authors:  Amish Acharya; Sheraz R Markar; Melody Ni; George B Hanna
Journal:  Surg Endosc       Date:  2016-08-05       Impact factor: 4.584

7.  The usefulness of procalcitonin in the diagnosis of appendicitis in children: a pilot study.

Authors:  Abu N G A Khan; Abdel Sawan; Antonios Likourezos; Mark Schnellinger; Estavan Garcia
Journal:  Emerg Med Int       Date:  2012-12-05       Impact factor: 1.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.